暄達醫學科技股份有限公司 Approved
最後更新時間 2025/07/18 , 07:14 AM
最後更新時間 2025/07/18 , 07:14 AM
負責人
Zheng,Wei-Xun
統一編號
53853674
成立日期
2012/05/23
資本額
NT$1,000,000,000
實收資本額
NT$203,040,000
股票代號
7726
電話
03-3287882
地址
No. 77, Keji 1st Rd., Guishan Dist., Taoyuan City, 333, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Zheng,Wei-Xun Chairman 55.60% YONG ZHAO ENTREPRENEURSHIP INVESTMENT CO., LTD.
Zheng,Feng-Xiang Director 55.60% YONG ZHAO ENTREPRENEURSHIP INVESTMENT CO., LTD.
Liu,Yi-Cen Director 55.60% YONG ZHAO ENTREPRENEURSHIP INVESTMENT CO., LTD.
Lai,Jun-Fu Director 0.00%
Long,Yu-Mei Independent Director 0.00%
Lin,Ze-Cong Independent Director 0.00%
Huang,Guo-Shi Independent Director 0.00%
營業項目
  • Manufacture of Other Medical Instruments and Supplies(332900)
  • Wholesale of Other Machinery and Equipment(464914)
  • Wholesale on a Fee or Contract Basis(451099)
  • Wholesale of General Merchandise(452000)
  • 公司歷程
  • Change Person in Charge to Zheng,Wei-Xun
    2021/02/24
  • Change Capital to 1,000,000,000
    2020/06/17
  • Change Capital to 300,000,000
    2015/11/11
  • Change Capital to 123,000,000
    2015/10/22
  • Change Capital to 100,000,000
    2013/09/24
  • Change Person in Charge to Wang,Shu-Fen
    2013/09/24
  • Change Capital to 95,000,000
    2013/06/06
  • Change Capital to 65,000,000
    2013/02/22
  • Change Capital to 35,000,000
    2012/10/23
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023 2022
    Operating income 184,347 466,364 335,311
    Operating cost 101,136 269,620 192,678
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 83,211 196,744 142,633
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 83,211 196,744 142,633
    Operating expenses 79,930 143,476 113,889
    Other gain (loss), net - - -
    Operating profit (loss) 3,281 53,268 28,744
    Non-operating income and expenses 11,890 3,164 7,296
    Net profit (loss) before tax 15,171 56,432 36,040
    Income tax expense (benefits) 5,851 11,992 7,181
    Net profit (loss) of ongoing business for the current period 9,320 44,440 28,859
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 9,320 44,440 28,859
    Other comprehensive profit (loss), net 1,164 294 159
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 10,484 44,734 29,018
    Net profit (loss) attributable to owners of parent company 9,320 44,440 28,859
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company 10,484 44,734 29,018
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 0 2 2
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities 26,760 1,964 33,036
    Net cash inflows (outflows) from investing activities -1,191 -3,520 -27,205
    Net cash inflow (outflow) from financing activities -8,259 47,497 -14,565
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 1,762 -2,194 -792
    Increase (decrease) in cash and cash equivalents in the current period 19,072 43,747 -9,526
    Beginning balance of cash and cash equivalents 173,156 129,409 138,935
    Ending balance of cash and cash equivalents 192,228 173,156 129,409
    項目 2024 2023 2022
    Current asset 452,720 476,742 334,562
    Non-current asset 60,835 66,700 80,166
    Total asset 513,555 543,442 414,728
    Current liability 182,532 180,753 147,464
    Non-current liability 5,000 11,212 30,089
    Total liability 187,532 191,965 177,553
    share capital 203,040 203,040 141,830
    Equity - secruity token - - -
    capital reserve 43,488 43,488 8,330
    retained earning 78,304 104,922 87,282
    Other equity 1,191 27 -267
    Treasury stock - - -
    Total equity attributable to owners of parent company 326,023 351,477 237,175
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 326,023 351,477 237,175
    Share capital awaiting retirement (unit: share) - - -
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 16 17 16
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • AEOTEX
  • Revo
  • Coziny
  • Envelop
  • Dual
  • DualCare
  • CARILEX
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。